Institutional investors hold a majority ownership of TEVA through the 50.15% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended March 2019, these large investors purchased a net $35.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HAREL MUTUAL FUNDS LTD. Bought 1.1 Million shares of Teva Pharmaceutical Indus...